<DOC>
	<DOCNO>NCT02215772</DOCNO>
	<brief_summary>Study investigate basic pharmacokinetics BI 44370 BS , metabolite CD 10419 BS , 14C-radioactivity include mass balance , excretion pathway , metabolism follow single oral administration 200 mg [ 14C ] BI 44370 BS healthy male volunteer evaluate safety tolerability follow single oral administration 200 mg [ 14C ] BI 44370 BS healthy male volunteer</brief_summary>
	<brief_title>Metabolism Pharmacokinetics 14C-BI 44370 BS Administered Oral Solution Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male accord follow criterion base upon complete medical history , include physical examination , vital sign ( blood pressure ( BP ) , pulse rate ( PR ) ) , 12lead ECG , clinical laboratory test Age ≥18 ≤65 year Body mass index ( BMI ) ≥18.0 BMI ≤30.0 kg/m2 Signed date write informed consent prior admission study accordance Good Clinical Practice ( GCP ) local legislation Any finding medical examination ( include BP , PR ECG ) deviate normal clinical relevance Any evidence clinically relevant concomitant disease Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History relevant orthostatic hypotension , faint spell blackouts Chronic , relevant acute infection History relevant allergy/hypersensitivity ( include allergy study drug excipients ) Intake drug long halflife ( &gt; 24 hour ) within least one month le 10 halflives respective drug prior administration trial Use drug might reasonably influence result trial base knowledge time protocol preparation within 10 day prior administration last sample Visit 2 collect Participation another trial investigational drug within two month prior administration trial Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke stay trial centre Alcohol abuse ( average 2 unit alcoholic beverage per day 14 unit per week ( 1 unit equal 1 pint [ 285 mL ] beer lager , 1 glass [ 125 mL ] wine , 25 mL shoot 40 % spirit ) ) Drug abuse Blood donation ( 100 mL within 60 day prior study drug administration trial ) Excessive physical activity ( within one week prior administration trial followup examination ) Any laboratory value outside reference range clinical relevance Inability comply dietary regimen study centre A marked baseline prolongation QT/QTc interval ( e.g. , repeated demonstration QTc interval &gt; 450 m ) Veins unsuitable blood sample PR interval &gt; 220 m QRS interval &gt; 120 m Exposure radiation diagnostic reason ( except dental Xrays plain Xrays thorax bony skeleton ( exclude spinal column ) ) , work participation medical trial previous year Irregular defecation pattern ( less per 2 day ) Not willing use adequate contraception ( condom use plus another form contraception e.g . spermicide , oral contraceptive take female partner , sterilisation , intrauterine device ) whole study period time first intake study drug three month last intake</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>